ARCUTIS BIOTHERAPEUTICS INC's ticker is ARQT and the CUSIP is 03969K108. A total of 140 filers reported holding ARCUTIS BIOTHERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is 0.08 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $4,275,558 | -12.2% | 448,642 | +1.4% | 0.01% | -17.6% |
| Q1 2023 | $4,867,269 | -2.1% | 442,479 | +31.8% | 0.02% | -5.6% |
| Q4 2022 | $4,969,633 | -61.5% | 335,786 | -50.3% | 0.02% | -28.0% |
| Q3 2022 | $12,902,440 | +35.4% | 675,190 | +51.0% | 0.02% | +38.9% |
| Q2 2022 | $9,531,598 | -30.3% | 447,264 | -37.0% | 0.02% | -5.3% |
| Q1 2022 | $13,672,202 | +122.5% | 709,886 | +139.6% | 0.02% | +18.8% |
| Q4 2021 | $6,144,000 | -0.7% | 296,253 | +14.3% | 0.02% | -5.9% |
| Q3 2021 | $6,190,000 | -53.4% | 259,084 | -46.8% | 0.02% | -10.5% |
| Q2 2021 | $13,282,000 | +104.5% | 486,728 | +116.8% | 0.02% | -5.0% |
| Q1 2021 | $6,496,000 | – | 224,548 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Frazier Life Sciences Management, L.P. | 8,434,232 | $162,443,000 | 13.84% |
| Bain Capital Life Sciences Investors, LLC | 3,979,292 | $76,641,000 | 7.44% |
| Pivotal bioVenture Partners Investment Advisor LLC | 569,041 | $10,960,000 | 5.19% |
| Logos Global Management LP | 1,500,000 | $28,890,000 | 3.75% |
| Omega Fund Management, LLC | 623,836 | $12,015,000 | 2.46% |
| Orbimed Advisors | 6,073,850 | $116,982,000 | 1.90% |
| MPM BioImpact LLC | 258,500 | $4,979,000 | 1.34% |
| 1492 Capital Management LLC | 75,192 | $1,448,000 | 0.77% |
| SECTORAL ASSET MANAGEMENT INC | 219,136 | $4,221,000 | 0.75% |
| EcoR1 Capital, LLC | 895,503 | $17,247,000 | 0.54% |